Table 3.

Comparisons of Blood and Stool Cytokines in Immunocompromised Subjects, Nonimmunocompromised Hosts, and Asymptomatic Carriers

AnalyteICH
(n = 42)
Non-ICH
(n = 50)
P ValueBHBF
Bloodq* = 0.01666q* = 0.01666
 G-CSF63.70 (15.63–627.78)28.16 (13.27–99.72).083NSNS
 IL-1015.63 (5.68–41.99)14.30 (2.92–33.35).291NSNS
 IL-154.73 (0.76–14.08)3.54 (0.76–9.41).165NSNS
 IL-40.21 (0.21–9.12)0.21 (0.21–31.92).753NSNS
 IL-610.68 (3.47–69.88)11.33 (1.87–39.43).688NSNS
 IL-857.11 (23.66–100.80)62.94 (26.92–115.58).470NSNS
 TNF-α15.20 (7.42–24.77)10.80 (7.42–18.36).154NSNS
Stoolq* = 0.01666q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–2.35).005SIGSIG
 IL-1β10.97 (1.57–195.10)9.71 (1.95–1595.77).331NSNS
 IL-85.11 (0.41–41.72)11.62 (2.77–109.73).068NSNS
AnalyteICH
(n = 42)
Non-ICH
(n = 50)
P ValueBHBF
Bloodq* = 0.01666q* = 0.01666
 G-CSF63.70 (15.63–627.78)28.16 (13.27–99.72).083NSNS
 IL-1015.63 (5.68–41.99)14.30 (2.92–33.35).291NSNS
 IL-154.73 (0.76–14.08)3.54 (0.76–9.41).165NSNS
 IL-40.21 (0.21–9.12)0.21 (0.21–31.92).753NSNS
 IL-610.68 (3.47–69.88)11.33 (1.87–39.43).688NSNS
 IL-857.11 (23.66–100.80)62.94 (26.92–115.58).470NSNS
 TNF-α15.20 (7.42–24.77)10.80 (7.42–18.36).154NSNS
Stoolq* = 0.01666q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–2.35).005SIGSIG
 IL-1β10.97 (1.57–195.10)9.71 (1.95–1595.77).331NSNS
 IL-85.11 (0.41–41.72)11.62 (2.77–109.73).068NSNS
Non-ICH
(n = 50)
ASC
(n = 31)
Bloodq* = 0.03571q* = 0.00714
 G-CSF28.16 (13.27–99.72)9.84 (3.80–21.19)<.001SIGSIG
 IL-1014.30 (2.92–33.35)2.05 (1.24–16.25).004SIGSIG
 IL-153.54 (0.76–9.41)0.76 (0.76–1.62).004SIGSIG
 IL-40.21 (0.21–31.92)0.41 (0.41–0.41).052NSNS
 IL-611.33 (1.87–39.43)0.54 (0.14–5.80).001SIGSIG
 IL-862.94 (26.92–115.58)21.00 (8.97–40.23)<.001SIGSIG
 TNF-α10.80 (7.42–18.36)8.53 (4.07–15.26).093NSNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–2.35)1.24 (1.24–1.24).053NSNS
 IL-1β9.71 (1.95–1595.77)0.56 (0.56–0.56)<.001SIGSIG
 IL-811.62 (2.77–109.73)0.41 (0.41–2.35)<.001SIGSIG
Non-ICH
(n = 50)
ASC
(n = 31)
Bloodq* = 0.03571q* = 0.00714
 G-CSF28.16 (13.27–99.72)9.84 (3.80–21.19)<.001SIGSIG
 IL-1014.30 (2.92–33.35)2.05 (1.24–16.25).004SIGSIG
 IL-153.54 (0.76–9.41)0.76 (0.76–1.62).004SIGSIG
 IL-40.21 (0.21–31.92)0.41 (0.41–0.41).052NSNS
 IL-611.33 (1.87–39.43)0.54 (0.14–5.80).001SIGSIG
 IL-862.94 (26.92–115.58)21.00 (8.97–40.23)<.001SIGSIG
 TNF-α10.80 (7.42–18.36)8.53 (4.07–15.26).093NSNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–2.35)1.24 (1.24–1.24).053NSNS
 IL-1β9.71 (1.95–1595.77)0.56 (0.56–0.56)<.001SIGSIG
 IL-811.62 (2.77–109.73)0.41 (0.41–2.35)<.001SIGSIG
ICH
(n = 42)
ASC
(n = 31)
Bloodq* = 0.05q* = 0.00714
 G-CSF63.70 (15.63–627.78)9.84 (3.80–21.19)<.001SIGSIG
 IL-1015.63 (5.68–41.99)2.05 (1.24–16.25)<.001SIGSIG
 IL-154.73 (0.76–14.08)0.76 (0.76–1.62)<.001SIGSIG
 IL-40.21 (0.21–9.12)0.41 (0.41–0.41).011SIGNS
 IL-610.68 (3.47–69.88)0.54 (0.14–5.80)<.001SIGSIG
 IL-857.11 (23.66–100.80)21.00 (8.97–40.23).001SIGSIG
 TNF-α15.20 (7.42–24.77)8.53 (4.07–15.26).010SIGNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–1.24).745NSNS
 IL-1β10.97 (1.57–195.10)0.56 (0.56–0.56)<.001SIGSIG
 IL-85.11 (0.41–41.72)0.41 (0.41–2.35)<.001SIGSIG
ICH
(n = 42)
ASC
(n = 31)
Bloodq* = 0.05q* = 0.00714
 G-CSF63.70 (15.63–627.78)9.84 (3.80–21.19)<.001SIGSIG
 IL-1015.63 (5.68–41.99)2.05 (1.24–16.25)<.001SIGSIG
 IL-154.73 (0.76–14.08)0.76 (0.76–1.62)<.001SIGSIG
 IL-40.21 (0.21–9.12)0.41 (0.41–0.41).011SIGNS
 IL-610.68 (3.47–69.88)0.54 (0.14–5.80)<.001SIGSIG
 IL-857.11 (23.66–100.80)21.00 (8.97–40.23).001SIGSIG
 TNF-α15.20 (7.42–24.77)8.53 (4.07–15.26).010SIGNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–1.24).745NSNS
 IL-1β10.97 (1.57–195.10)0.56 (0.56–0.56)<.001SIGSIG
 IL-85.11 (0.41–41.72)0.41 (0.41–2.35)<.001SIGSIG

Unless otherwise indicated, data are presented as median (interquartile range) picograms per milliliter. Data include only cytokines that were found to be statistically significantly different using both Benjamini-Hochberg and Bonferroni methods.

Abbreviations: ASC, asymptomatic carrier of Clostridioides difficile; BF, Bonferroni corrected significance level (q*); BH, Benjamini-Hochberg corrected significance level (q*); G-CSF, granulocyte colony-stimulating factor; ICH, immunocompromised host; IL, interleukin; non-ICH, nonimmunocompromised host; NS, nonsignificant, SIG, significant; TNF-α, tumor necrosis factor alpha.

Table 3.

Comparisons of Blood and Stool Cytokines in Immunocompromised Subjects, Nonimmunocompromised Hosts, and Asymptomatic Carriers

AnalyteICH
(n = 42)
Non-ICH
(n = 50)
P ValueBHBF
Bloodq* = 0.01666q* = 0.01666
 G-CSF63.70 (15.63–627.78)28.16 (13.27–99.72).083NSNS
 IL-1015.63 (5.68–41.99)14.30 (2.92–33.35).291NSNS
 IL-154.73 (0.76–14.08)3.54 (0.76–9.41).165NSNS
 IL-40.21 (0.21–9.12)0.21 (0.21–31.92).753NSNS
 IL-610.68 (3.47–69.88)11.33 (1.87–39.43).688NSNS
 IL-857.11 (23.66–100.80)62.94 (26.92–115.58).470NSNS
 TNF-α15.20 (7.42–24.77)10.80 (7.42–18.36).154NSNS
Stoolq* = 0.01666q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–2.35).005SIGSIG
 IL-1β10.97 (1.57–195.10)9.71 (1.95–1595.77).331NSNS
 IL-85.11 (0.41–41.72)11.62 (2.77–109.73).068NSNS
AnalyteICH
(n = 42)
Non-ICH
(n = 50)
P ValueBHBF
Bloodq* = 0.01666q* = 0.01666
 G-CSF63.70 (15.63–627.78)28.16 (13.27–99.72).083NSNS
 IL-1015.63 (5.68–41.99)14.30 (2.92–33.35).291NSNS
 IL-154.73 (0.76–14.08)3.54 (0.76–9.41).165NSNS
 IL-40.21 (0.21–9.12)0.21 (0.21–31.92).753NSNS
 IL-610.68 (3.47–69.88)11.33 (1.87–39.43).688NSNS
 IL-857.11 (23.66–100.80)62.94 (26.92–115.58).470NSNS
 TNF-α15.20 (7.42–24.77)10.80 (7.42–18.36).154NSNS
Stoolq* = 0.01666q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–2.35).005SIGSIG
 IL-1β10.97 (1.57–195.10)9.71 (1.95–1595.77).331NSNS
 IL-85.11 (0.41–41.72)11.62 (2.77–109.73).068NSNS
Non-ICH
(n = 50)
ASC
(n = 31)
Bloodq* = 0.03571q* = 0.00714
 G-CSF28.16 (13.27–99.72)9.84 (3.80–21.19)<.001SIGSIG
 IL-1014.30 (2.92–33.35)2.05 (1.24–16.25).004SIGSIG
 IL-153.54 (0.76–9.41)0.76 (0.76–1.62).004SIGSIG
 IL-40.21 (0.21–31.92)0.41 (0.41–0.41).052NSNS
 IL-611.33 (1.87–39.43)0.54 (0.14–5.80).001SIGSIG
 IL-862.94 (26.92–115.58)21.00 (8.97–40.23)<.001SIGSIG
 TNF-α10.80 (7.42–18.36)8.53 (4.07–15.26).093NSNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–2.35)1.24 (1.24–1.24).053NSNS
 IL-1β9.71 (1.95–1595.77)0.56 (0.56–0.56)<.001SIGSIG
 IL-811.62 (2.77–109.73)0.41 (0.41–2.35)<.001SIGSIG
Non-ICH
(n = 50)
ASC
(n = 31)
Bloodq* = 0.03571q* = 0.00714
 G-CSF28.16 (13.27–99.72)9.84 (3.80–21.19)<.001SIGSIG
 IL-1014.30 (2.92–33.35)2.05 (1.24–16.25).004SIGSIG
 IL-153.54 (0.76–9.41)0.76 (0.76–1.62).004SIGSIG
 IL-40.21 (0.21–31.92)0.41 (0.41–0.41).052NSNS
 IL-611.33 (1.87–39.43)0.54 (0.14–5.80).001SIGSIG
 IL-862.94 (26.92–115.58)21.00 (8.97–40.23)<.001SIGSIG
 TNF-α10.80 (7.42–18.36)8.53 (4.07–15.26).093NSNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–2.35)1.24 (1.24–1.24).053NSNS
 IL-1β9.71 (1.95–1595.77)0.56 (0.56–0.56)<.001SIGSIG
 IL-811.62 (2.77–109.73)0.41 (0.41–2.35)<.001SIGSIG
ICH
(n = 42)
ASC
(n = 31)
Bloodq* = 0.05q* = 0.00714
 G-CSF63.70 (15.63–627.78)9.84 (3.80–21.19)<.001SIGSIG
 IL-1015.63 (5.68–41.99)2.05 (1.24–16.25)<.001SIGSIG
 IL-154.73 (0.76–14.08)0.76 (0.76–1.62)<.001SIGSIG
 IL-40.21 (0.21–9.12)0.41 (0.41–0.41).011SIGNS
 IL-610.68 (3.47–69.88)0.54 (0.14–5.80)<.001SIGSIG
 IL-857.11 (23.66–100.80)21.00 (8.97–40.23).001SIGSIG
 TNF-α15.20 (7.42–24.77)8.53 (4.07–15.26).010SIGNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–1.24).745NSNS
 IL-1β10.97 (1.57–195.10)0.56 (0.56–0.56)<.001SIGSIG
 IL-85.11 (0.41–41.72)0.41 (0.41–2.35)<.001SIGSIG
ICH
(n = 42)
ASC
(n = 31)
Bloodq* = 0.05q* = 0.00714
 G-CSF63.70 (15.63–627.78)9.84 (3.80–21.19)<.001SIGSIG
 IL-1015.63 (5.68–41.99)2.05 (1.24–16.25)<.001SIGSIG
 IL-154.73 (0.76–14.08)0.76 (0.76–1.62)<.001SIGSIG
 IL-40.21 (0.21–9.12)0.41 (0.41–0.41).011SIGNS
 IL-610.68 (3.47–69.88)0.54 (0.14–5.80)<.001SIGSIG
 IL-857.11 (23.66–100.80)21.00 (8.97–40.23).001SIGSIG
 TNF-α15.20 (7.42–24.77)8.53 (4.07–15.26).010SIGNS
Stoolq* = 0.03333q* = 0.01666
 IL-101.24 (1.24–1.24)1.24 (1.24–1.24).745NSNS
 IL-1β10.97 (1.57–195.10)0.56 (0.56–0.56)<.001SIGSIG
 IL-85.11 (0.41–41.72)0.41 (0.41–2.35)<.001SIGSIG

Unless otherwise indicated, data are presented as median (interquartile range) picograms per milliliter. Data include only cytokines that were found to be statistically significantly different using both Benjamini-Hochberg and Bonferroni methods.

Abbreviations: ASC, asymptomatic carrier of Clostridioides difficile; BF, Bonferroni corrected significance level (q*); BH, Benjamini-Hochberg corrected significance level (q*); G-CSF, granulocyte colony-stimulating factor; ICH, immunocompromised host; IL, interleukin; non-ICH, nonimmunocompromised host; NS, nonsignificant, SIG, significant; TNF-α, tumor necrosis factor alpha.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close